Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5362
Gene Symbol: PLXNA2
PLXNA2
0.100 Biomarker group BEFREE 3D optical coherence tomography angiography (OCT-A) is a novel and non-invasive imaging modality for analyzing retinal diseases. 31647423 2019
Entrez Id: 5362
Gene Symbol: PLXNA2
PLXNA2
0.100 Biomarker group BEFREE Both OCT devices had comparable repeatability for retinal thickness measurement in normal eyes and eyes with retinal disease. 30650130 2019
Entrez Id: 5362
Gene Symbol: PLXNA2
PLXNA2
0.100 Biomarker group BEFREE The authors report a case of Purtscher's retinopathy whose optical coherence tomography angiography (OCT-A) analysis allows us to better understand the vascular network of the optic disk. 30852735 2019
Entrez Id: 5362
Gene Symbol: PLXNA2
PLXNA2
0.100 Biomarker group BEFREE This case demonstrates that SD-OCT may be easily used in young children to confirm retinal disease, quantify the extent of retinal damage, and monitor disease progression. 29551606 2018
Entrez Id: 5362
Gene Symbol: PLXNA2
PLXNA2
0.100 Biomarker group BEFREE A New OCT Finding in Purtscher-Like Retinopathy. 29304270 2018
Entrez Id: 5362
Gene Symbol: PLXNA2
PLXNA2
0.100 Biomarker group BEFREE Loss of integrity of the ellipsoid zone (EZ) on OCT in people with retinal disease has been associated with loss of visual function and is a useful measure of retinal disease progression. 28856832 2018
Entrez Id: 5362
Gene Symbol: PLXNA2
PLXNA2
0.100 Biomarker group BEFREE The role of OCT-A in retinal disease management. 30175386 2018
Entrez Id: 5362
Gene Symbol: PLXNA2
PLXNA2
0.100 GeneticVariation group BEFREE To evaluate the diagnostic accuracy of OCT angiography (OCT-A) detecting or predicting choroidal neovascularization (CNV), by ophthalmologists of disparate degrees of skills in retinal diseases, using spectral domain optical coherence tomography (SD-OCT) and fluorescein angiography (FA) as a standard reference. 28547533 2018
Entrez Id: 5362
Gene Symbol: PLXNA2
PLXNA2
0.100 Biomarker group BEFREE This paper proposes a method for automatic classification of spectral domain OCT data for the identification of patients with retinal diseases such as Diabetic Macular Edema (DME). 28187882 2017
Entrez Id: 5362
Gene Symbol: PLXNA2
PLXNA2
0.100 Biomarker group BEFREE We performed a prospective, observational clinical study to determine if ultra-widefield fluorescein angiography (UWFA), spectral-domain optical coherence tomography (SD-OCT), and optical coherence tomography angiography (OCT-A) detect more-frequent retinopathy in adolescents with SCD. 28860042 2017
Entrez Id: 5362
Gene Symbol: PLXNA2
PLXNA2
0.100 Biomarker group BEFREE In KCNV2 retinopathy foveal morphological changes are evident on SD-OCT even in the early stages of disease. 21558291 2012